Live Breaking News & Updates on Jennifer Michaelson

Stay updated with breaking news from Jennifer michaelson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Cullinan Therapeutics (NASDAQ:CGEM) Stock Price Down 4.5%

Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Get Free Report) fell 4.5% on Tuesday . The company traded as low as $22.99 and last traded at $23.05. 266,559 shares traded hands during trading, a decline of 58% from the average session volume of 630,100 shares. The stock had previously closed at $24.13. Wall Street Analysts Forecast Growth […] ....

United States , William Blair , Stifel Nicolaus , Jennifer Michaelson , Zurcher Kantonalbank Zurich Cantonalbank , Cullinan Therapeutics Inc , Securities Exchange Commission , China Universal Asset Management Co , Cullinan Therapeutics Company Profile , Ameritas Investment Partners Inc , Vontobel Holding Ltd , Annandale Capital , Cullinan Therapeutics , Get Free Report , Exchange Commission , Investment Partners , Universal Asset Management , Kantonalbank Zurich Cantonalbank , Cullinan Therapeutics Daily ,

HC Wainwright Trims Cullinan Oncology (NASDAQ:CGEM) Target Price to $28.00

Cullinan Oncology (NASDAQ:CGEM – Free Report) had its price target decreased by HC Wainwright from $29.00 to $28.00 in a research report released on Thursday, Benzinga reports. HC Wainwright currently has a buy rating on the stock. Several other equities analysts have also issued reports on CGEM. Jonestrading lifted their price objective on shares of […] ....

United States , William Blair , Zurcher Kantonalbank Zurich Cantonalbank , Stifel Nicolaus , Jennifer Michaelson , York Mellon Corp , Barclays Plc , Cullinan Oncology Inc , Cullinan Oncology Company Profile , Sg Americas Securities , Cullinan Oncology , Free Report , Oncology Trading Down , Get Free Report , New York Mellon Corp , Kantonalbank Zurich Cantonalbank , Cullinan Oncology Daily ,

Cullinan Oncology, Inc. (NASDAQ:CGEM) Given Average Rating of "Buy" by Analysts

Shares of Cullinan Oncology, Inc. (NASDAQ:CGEM – Get Free Report) have been given a consensus rating of “Buy” by the seven ratings firms that are presently covering the company, Marketbeat Ratings reports. Seven research analysts have rated the stock with a buy recommendation. The average twelve-month price objective among brokers that have issued a report […] ....

United States , Jennifer Michaelson , Stifel Nicolaus , Pricet Rowe Associates Inc , Mirae Asset Global Investments Co , Ameritas Investment Partners Inc , Cullinan Oncology Inc , China Universal Asset Management Co , Parkman Healthcare Partners , Securities Exchange Commission , Cullinan Oncology , Get Free Report , Marketbeat Ratings , Oncology Trading Down , Exchange Commission , Investment Partners , Asset Global Investments , Universal Asset Management , Healthcare Partners , Get Free , Cullinan Oncology Daily ,

Brokerages Set Cullinan Oncology, Inc. (NASDAQ:CGEM) Price Target at $31.00

Cullinan Oncology, Inc. (NASDAQ:CGEM – Get Free Report) has been given an average rating of “Buy” by the seven ratings firms that are covering the stock, MarketBeat reports. Seven analysts have rated the stock with a buy rating. The average 12 month target price among brokerages that have covered the stock in the last year […] ....

United States , Jennifer Michaelson , Stifel Nicolaus , William Blair , Parkman Healthcare Partners , Securities Exchange Commission , Cullinan Oncology Inc , Affinity Asset Advisors , Franklin Resources Inc , Cullinan Oncology , Get Free Report , Exchange Commission , Asset Advisors , Healthcare Partners , Trexquant Investment , Oncology Stock Down , Get Free , Cullinan Oncology Daily ,